As of 2025-07-07, the Forward P/E of Protalix Biotherapeutics Inc (PLX) is 4.92.
Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.